The findings with edoxaban are adding further evidence to the hypothesis that inhibition of FXa and thrombin with NOACs may be beneficial in preventing the progression of atherosclerosis, fibrosis, and other inflammatory conditions. Here, F10 is linked to atherosclerosis.